BRIEF published on 06/03/2024 at 08:35, 2 years 2 months ago FDE repurchases shares through its share repurchase program Share Buyback 2024 ENERGY FDE Goals
BRIEF published on 06/03/2024 at 08:05, 2 years 2 months ago OTAQ Plc Announces Total Voting Rights Update Shares OTAQ Plc Total Voting Rights FCA Transparency Rules
BRIEF published on 06/03/2024 at 08:05, 2 years 2 months ago Fuller, Smith & Turner PLC: Total Voting Rights and Treasury Shares Share Capital Treasury Shares Financial Announcement Total Voting Rights Fuller, Smith & Turner
BRIEF published on 06/03/2024 at 08:05, 2 years 2 months ago Cairn Homes Plc: Transaction in Own Shares London Stock Exchange Share Buyback Euronext Dublin Cairn Homes Stock Repurchase
BRIEF published on 06/03/2024 at 08:05, 2 years 2 months ago Amendment to the convertible bond financing contract: rescheduling over three years Convertible Bonds Treasury Funding MUNIC Rescheduling
BRIEF published on 06/03/2024 at 07:35, 2 years 2 months ago STS Group AG Reports Strong First Quarter Performance in 2024 EBITDA Sales Revenue Growth Automotive First Quarter 2024
BRIEF published on 06/03/2024 at 07:35, 2 years 2 months ago Mutares Successfully Acquires FSL Ladenbau GmbH Acquisition Mutares Ganter Group Shopfitting FSL Ladenbau
BRIEF published on 06/03/2024 at 07:35, 2 years 2 months ago Vallourec: André Lacerda appointed Director of South America (Tubes Activities) South America Nomination Vallourec André Lacerda Tubes
BRIEF published on 06/03/2024 at 07:35, 2 years 2 months ago Transgene includes the first patient in Phase II of the study of its TG4050 vaccine against head and neck cancers Head And Neck Cancer Transgene TG4050 Phase II Therapeutic Vaccine
BRIEF published on 06/03/2024 at 07:35, 2 years 2 months ago GenSight Biologics Welcomes William Monteith to the Board of Directors Board Of Directors Nomination GenSight Biologics William Monteith Gene Therapies
Published on 08/26/2026 at 22:30, 26 minutes ago AI/ML Innovations Inc. Closes First Tranche of Private Placement
Published on 08/26/2026 at 22:30, 26 minutes ago Blueberries Medical Announces Closing of C$1.1 Million Non-Brokered Private Placement
Published on 08/26/2026 at 21:15, 1 hour 41 minutes ago Announces Private Placement of Convertible Promissory Notes
Published on 08/26/2026 at 20:35, 2 hours 21 minutes ago RUM Reports Quarterly Financial Results for June 30, 2026
Published on 08/26/2026 at 17:40, 5 hours 16 minutes ago Camino Closes $5.8 Million Brokered Private Placement of Units and Concurrent $9.4 Million Non-Brokered Private Placement of Convertible Debentures
Published on 08/26/2026 at 18:44, 4 hours 12 minutes ago AUSTRIACARD HOLDINGS AG: Press Release H1 2026 Financial Results
Published on 08/26/2026 at 18:40, 4 hours 16 minutes ago MBC GROUP REVEALS MBC GAMES STUDIO WITH DEBUT TITLE UNVEILING AT GAMESCOM
Published on 08/26/2026 at 18:30, 4 hours 26 minutes ago Heidelberg Pharma AG and Huadong Medicine Receive NMPA Approval for Clinical Trial of HDP-101 Combination Therapy in China
Published on 08/26/2026 at 18:00, 4 hours 56 minutes ago MHM Corporate: reduces the nominal value of its shares to €0.011
Published on 08/26/2026 at 17:45, 5 hours 11 minutes ago LIGHTON: Information concerning the total number of voting rights and shares in the share capital as of 31 July 2026.
Published on 08/26/2026 at 18:02, 4 hours 54 minutes ago Altareit: Altarea press release regarding the Primonial matter
Published on 08/26/2026 at 18:00, 4 hours 56 minutes ago Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)
Published on 08/25/2026 at 17:45, 1 day 5 hours ago CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 08/25/2026 at 17:45, 1 day 5 hours ago Imerys-08-2026-information-share-capital-and-voting-rights-as-of-31-July-2026
